4//SEC Filing
Geller Matthew 4
Accession 0001062993-11-002388
CIK 0000875622other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 7:21 PM ET
Size
4.7 KB
Accession
0001062993-11-002388
Insider Transaction Report
Form 4
Geller Matthew
Director
Transactions
- Sale
Common Stock
2011-05-24$24.08/sh−7,700$185,440→ 10,000 total
Footnotes (1)
- [F1]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.00 to $24.10. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001446201
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 7:21 PM ET
- Size
- 4.7 KB